Onyema Ogbuagu

Featured in: Favicon

newsweek.com Favicon

sagepub.com Favicon

biomedcentral.com Favicon

tandfonline.com Favicon

medscape.com Favicon

thelancet.com Favicon

contagionlive.com Favicon

ghspjournal.org Favicon

journals.sagepub.com Favicon

jmedicalcasereports.biomedcentral.com

Articles

Lenacapavir Offers Promising Step Forward in HIV Prevention: Q&A With Onyema Ogbuagu, MBBCh, FACP, FIDSA

1 week ago | ajmc.com | Julia Bonavitacola |Onyema Ogbuagu

The FDA approval of lenacapavir on June 19 offers a new treatment that can help to reduce the incidence of HIV globally, with approximately 100% efficacy when used as pre-exposure prophylaxis (PrEP) to prevent the incidence of HIV.

Contact details

Emails

[email protected]

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →